- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Research
- About
The Catalyst
Yesterday, the New York Times’ Well blog posted a commentary on DTC advertising. Although its underlying tone was one of skepticism, it did briefly touch on a couple of useful points.
For example, the article noted: “It’s difficult to ascertain...
I think it’s great that billionaire David Rubenstein has decided to donate half the $15 million needed to repair the damage to the Washington Monument from the earthquake last year. While I’m no David Rubenstein, I do appreciate the importance of giving back to your community, as do my colleagues. The staff at PhRMA have been participating in St. Matthew’s Cathedral’s...
In his recent commentary, Merill Goozner of the Fiscal Times looks at the affordability of cancer medicines. Goozner rightly points out that the biopharmaceutical industry is continuing to invest heavily in new treatments for this disease. However,...
The Spotlight
Check out the George Washington University School of Medicine release 'Institute of Biomedical Sciences Student Awarded Two-Year Fellowship from PhRMA Foundation.' We're excited about this.
WASHINGTON, DC (Jan 26, 2012)—Lindsay Garvin, a doctoral candidate pursuing a Ph.D. in Microbiology and Immunology as part of the Institute of Biomedical Sciences, a joint program with the GW School of Medicine and Health Sciences and the GW Columbian College of Arts and Sciences, has been awarded a...
January 26 at 7:43pm
Facebook/Twitter Lists
In his speech tonight, President Barack Obama spoke about the value of basic research and called on Congress not to "let other countries win the race for the future." What are your ideas to help make this a reality?
likes: 11 | comments: 0
Thanks Pharmaphorum for sharing Dr. Jan Lundberg's story. Learn more about what's being done to beat Alzheimer's disease.
likes: 10 | comments: 0
President Obama will deliver his annual State of the Union (SOTU) address tomorrow night. Jennifer Wall writes in the Catalyst, she'd like to see a focus on medical innovation. How about you? What is it that you’d like the President to focus on in his State of the Union address tomorrow night?
likes: 5 | comments: 3
How many tries does it take to design a drug that gets to market? [Infographic] http://t.co/YjU5mYvQ
01.25.2012 // Retweets: 6
"#Counterfeiting is a terrifyingly large and unfortunately booming business" - @KaelanAtPhRMA http://t.co/PHmV8kxy
01.25.2012 // Retweets: 2
Re: manufacturing, we need policies to preserve innovation so America's most innovative sectors can create more jobs and bolster economy
01.24.2012 // Retweets: 2
"Progress can continue but gov't & industry must work together to move #innovation goal post forward" http://t.co/igk82qiq
01.24.2012 // Retweets: 2
Please RT! Institute of Biomedical Sciences Student Awarded 2-Year Fellowship from @PhRMAFoundation http://t.co/7VJ9IsqO @GWSMHS
01.26.2012 // Retweets: 2
